Literature DB >> 15136042

Fitness increase of memory genomes in a viral quasispecies.

Armando Arias1, Carmen M Ruiz-Jarabo, Cristina Escarmís, Esteban Domingo.   

Abstract

Viral quasispecies may contain a subset of minority genomes that reflect those genomic sequences that were dominant at an early phase of quasispecies evolution. Such minority genomes are referred to as memory in viral quasispecies. A memory marker previously characterized in foot-and-mouth disease virus (FMDV) is an internal oligoadenylate tract of variable length that became dominant upon serial plaque-to-plaque transfers of FMDV clones. During large population passages, genomes with internal oligoadenylate were outcompeted by wild-type revertants but remained in the mutant spectra as memory genomes. Here, we report a quantification of relative fitness of several FMDV clones, harboring internal oligoadenylate tracts of different length, and that were retrieved at early or late times (passage number) after implementation of memory. The results show that for any given length range of the oligoadenylate, maintenance in memory resulted in an increase in relative fitness, comparable to the increase undergone by the entire population. The fitness increase is in agreement with the Red Queen hypothesis, and implies a replicative memory mechanism. Thus, permanence of memory genomes may be a source of high fitness variants despite their initial low fitness, and despite having remained hidden in mutant spectra. This reinforces the interest of diagnosing minority genomes during chronic human and animal viral infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15136042     DOI: 10.1016/j.jmb.2004.03.061

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  16 in total

Review 1.  Viral quasispecies evolution.

Authors:  Esteban Domingo; Julie Sheldon; Celia Perales
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

2.  Molecular epidemiology of the foot-and-mouth disease virus outbreak in the United Kingdom in 2001.

Authors:  Eleanor M Cottam; Daniel T Haydon; David J Paton; John Gloster; John W Wilesmith; Nigel P Ferris; Geoff H Hutchings; Donald P King
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

3.  Emergence of mammalian cell-adapted vesicular stomatitis virus from persistent infections of insect vector cells.

Authors:  Isabel S Novella; Bonnie E Ebendick-Corpus; Selene Zárate; Eric L Miller
Journal:  J Virol       Date:  2007-04-11       Impact factor: 5.103

Review 4.  Quasispecies and virus.

Authors:  Esteban Domingo; Celia Perales
Journal:  Eur Biophys J       Date:  2018-02-03       Impact factor: 1.733

5.  Role of the mutant spectrum in adaptation and replication of West Nile virus.

Authors:  Alexander T Ciota; Kiet A Ngo; Amy O Lovelace; Anne F Payne; Yangsheng Zhou; Pei-Yong Shi; Laura D Kramer
Journal:  J Gen Virol       Date:  2007-03       Impact factor: 3.891

6.  Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe.

Authors:  Macarena Sierra; Antero Airaksinen; Claudia González-López; Rubén Agudo; Armando Arias; Esteban Domingo
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

7.  Deletion mutants of VPg reveal new cytopathology determinants in a picornavirus.

Authors:  Armando Arias; Celia Perales; Cristina Escarmís; Esteban Domingo
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

8.  Biological effect of Muller's Ratchet: distant capsid site can affect picornavirus protein processing.

Authors:  Cristina Escarmís; Celia Perales; Esteban Domingo
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

9.  Adaptation of two flaviviruses results in differences in genetic heterogeneity and virus adaptability.

Authors:  Alexander T Ciota; Amy O Lovelace; Susan A Jones; Anne Payne; Laura D Kramer
Journal:  J Gen Virol       Date:  2007-09       Impact factor: 3.891

10.  Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naïve chronic HBV patients.

Authors:  Mostafa Mahabadi; Mehdi Norouzi; Seyed Moayyed Alavian; Katayoon Samimirad; Talat Mokhtari Azad; Esmaeil Saberfar; Mahmood Mahmoodi; Fatemeh Ramezani; Hadi Karimzadeh; Reza Malekzadeh; Ghodrat Montazeri; Azim Nejatizadeh; Masood Ziaee; Farshid Abedi; Behrooz Ataei; Majid Yaran; Babak Sayad; Mohammad Hossein Somi; Gholamreza Sarizadeh; Ismaeil Sanei-Moghaddam; Fariborz Mansour-Ghanaei; Houshang Rafatpanah; Mohammad Amin Pourhosseingholi; Hossain Keyvani; Ebrahim Kalantari; Mehdi Saberifiroozi; Mohammad Ali Judaki; Shiva Ghamari; Maryam Daram; Zeinab Fazeli; Zahra Goodarzi; Abolfazl Khedive; Abdolvahab Moradi; Seyed Mohamad Jazayeri
Journal:  Hepat Mon       Date:  2013-01-20       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.